IDEAS home Printed from https://ideas.repec.org/a/eur/ejmnjr/68.html
   My bibliography  Save this article

Pharmaceutical Management in the Context of Artificial Intelligence

Author

Listed:
  • Ana-Maria Pesterau

    (University of Medicine and Pharmacy, ”Carol Davila”, Bucharest, Romania)

  • Sirbu Rodica
  • Emin Cadar

Abstract

The permanent trend of progress has led to new solutions applied to computer science and technology, these two elements have taken over all dimensions of science. Artificial intelligence (AI) is a branch of computer science that has penetrated all areas, from basic engineering to the pharmaceutical industry. Intelligence has found its way into pharmaceutical, medical, and healthcare applications. In recent times, conventional methods of drug design have been replaced by computer-aided drug design. Artificial intelligence is widely used to improve design techniques, the time needed for drug production, and to prevent drug interactions. Artificial intelligence technology and management in the pharmaceutical sector is used at every stage of the drug design procedure, which reduces health risks related to preclinical studies and also substantially reduces costs. Artificial intelligence-based pharmaceutical management is an effective tool for extracting fundamental pharmacological data, but it is also an advantage in the machine learning process.

Suggested Citation

  • Ana-Maria Pesterau & Sirbu Rodica & Emin Cadar, 2023. "Pharmaceutical Management in the Context of Artificial Intelligence," European Journal of Medicine and Natural Sciences Articles, Revistia Research and Publishing, vol. 6, July - De.
    • Handle: RePEc:eur:ejmnjr:68
    DOI: 10.26417/584hib46s
    as

    Download full text from publisher

    File URL: https://revistia.com/index.php/ejmn/article/view/2022
    Download Restriction: no
    File URL: https://revistia.com/files/articles/ejmn_v6_i2_23/Pesterau.pdf
    Download Restriction: no
    File URL: https://libkey.io/10.26417/584hib46s?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eur:ejmnjr:68. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Revistia Research and Publishing (email available below). General contact details of provider: https://revistia.com/index.php/ejmn .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.